Structures of α-Synuclein Filaments from Multiple System Atrophy

dc.contributor.authorSchweighauser, Manuel
dc.contributor.authorShi, Yang
dc.contributor.authorTarutani, Airi
dc.contributor.authorKametani, Fuyuki
dc.contributor.authorMurzin, Alexey G.
dc.contributor.authorGhetti, Bernardino
dc.contributor.authorMatsubara, Tomoyasu
dc.contributor.authorTomita, Taisuke
dc.contributor.authorAndo, Takashi
dc.contributor.authorHasegawa, Kazuko
dc.contributor.authorMurayama, Shigeo
dc.contributor.authorYoshida, Mari
dc.contributor.authorHasegawa, Masato
dc.contributor.authorScheres, Sjors H.W.
dc.contributor.authorGoedert, Michel
dc.contributor.departmentPathology and Laboratory Medicine, School of Medicineen_US
dc.date.accessioned2022-06-23T17:28:33Z
dc.date.available2022-06-23T17:28:33Z
dc.date.issued2020-09
dc.description.abstractSynucleinopathies, which include multiple system atrophy (MSA), Parkinson's disease, Parkinson's disease with dementia and dementia with Lewy bodies (DLB), are human neurodegenerative diseases1. Existing treatments are at best symptomatic. These diseases are characterized by the presence of, and believed to be caused by the formation of, filamentous inclusions of α-synuclein in brain cells2,3. However, the structures of α-synuclein filaments from the human brain are unknown. Here, using cryo-electron microscopy, we show that α-synuclein inclusions from the brains of individuals with MSA are made of two types of filament, each of which consists of two different protofilaments. In each type of filament, non-proteinaceous molecules are present at the interface of the two protofilaments. Using two-dimensional class averaging, we show that α-synuclein filaments from the brains of individuals with MSA differ from those of individuals with DLB, which suggests that distinct conformers or strains characterize specific synucleinopathies. As is the case with tau assemblies4-9, the structures of α-synuclein filaments extracted from the brains of individuals with MSA differ from those formed in vitro using recombinant proteins, which has implications for understanding the mechanisms of aggregate propagation and neurodegeneration in the human brain. These findings have diagnostic and potential therapeutic relevance, especially because of the unmet clinical need to be able to image filamentous α-synuclein inclusions in the human brain.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationSchweighauser M, Shi Y, Tarutani A, et al. Structures of α-synuclein filaments from multiple system atrophy. Nature. 2020;585(7825):464-469. doi:10.1038/s41586-020-2317-6en_US
dc.identifier.urihttps://hdl.handle.net/1805/29424
dc.language.isoen_USen_US
dc.publisherSpringer Natureen_US
dc.relation.isversionof10.1038/s41586-020-2317-6en_US
dc.relation.journalNatureen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectBrainen_US
dc.subjectInclusion bodiesen_US
dc.subjectMultiple system atrophyen_US
dc.subjectPutamenen_US
dc.subjectalpha-Synucleinen_US
dc.titleStructures of α-Synuclein Filaments from Multiple System Atrophyen_US
dc.typeArticleen_US
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116528/en_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
EMS107716.pdf
Size:
4.24 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: